Small Molecule API Market Research Report 2019: Industry Size, Share, Trends, Growth and Opportunity Assessment, Regional Analysis and Segmentation By Types (Synthetic/Chemical API, Biological API), by Application (Cardiovascular, Oncology, Diabetes, Immunological Disorders and Others), by Manufacturing Method (In-House, Contract) – Forecast To 2027
The global small molecule API market is anticipated to surpass a valuation of USD 279.7 million, attaining a CAGR of 7% during the forecast period (2016-2027), Market Research Future (MRFR) unveils in a detailed report. Small molecule API is an active ingredient used for pharmaceutical development. It is highly used for the regulation of biological processes. API is the combination of substances that may have a direct effect on treatment, diagnosis, mitigation, and prevention of diseases. These molecules can be administered orally and can be absorbed by the body easily. They easily reach to the intracellular site of action due to its small size.
The major players operating in the global small molecule API market include Allergan Plc, Albemarle Corporation, Cambrex Corporation, Aurobindo Pharma, GlaxoSmithKline Plc, Dr. Reddy’s Laboratories Ltd, Merck Sharp & Dohme Corp., Lonza, Novartis AG, Mylan N.V., Siegfried AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd., and others.
Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/763
Market Potential and Pitfalls
The global small molecule API market has witnessed a tectonic surge over the past few years, mainly due to the increasing demand for small molecule drugs, recent developments in the pharmaceutical industry, and entry of big CMO’s into the business. The pharmaceutical sector is making tremendous profits and is well equipped with developed infrastructure. This growth in the pharmaceutical sector is driving the small molecule API market globally. With the rising incidences of diseases and the discovery of new viruses are predicted to impact the growth of the market positively. Moreover, the increased occurrence of cancer and cardiovascular disease is estimated to accelerate the competition among the market players, thereby encouraging its growth across the globe. The increased adoption of generic drugs has led to affordable healthcare expenditure and has further increased the production of small molecule APIs. Such factors are estimated to promote the growth of the market in the foreseeable future.
June 2019: Cambrex Corporation has recently announced three senior appointments which will support the company’s strategy to prepare the Contract Development & Manufacturing Organization of choice for small molecules within the pharmaceutical sector.
The global small molecule API market and is expected to reach $279.7 billion by 2027.
Synthetic/Chemical API holds the largest share of 81.4% of the global small molecule API market.
North America holds the largest market share of 38% of global small molecule API market and is anticipated to reach $106.3 billion by the end of forecast period.
Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 7.3% during the forecast period.
Cardiovascular disorder segment holds the largest market share in 2015, and expected to continue the similar growth throughout the forecast period.
- Small Molecule Drug manufacturers & Suppliers
- API manufacturers & Suppliers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Academic Institutes and Universities
Global Small Molecule API Market: Segmental Analysis
The global small molecule API market is segmented on the basis of type, manufacturing method, and application.
By type, the small molecule API market is segmented into synthetic/chemical API, and biological API. Of these, synthetic/chemical API acquires 81.4% of the market share and is likely to retain its pole position over the review period.
By application, the small molecule API market is segmented into oncology, cardiovascular, immunological disorders, diabetes, and others. Of these, the cardiovascular segment is predicted to obtain the maximum share and is likely to register healthy growth in the foreseeable future.
Based on manufacturing method, the market is bifurcated into in-house and contract.
Geographically, the small molecule API market spans across Europe, North America, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, North America acquires the lion’s share in the global market and is likely to retain its share in the foreseeable future. The market growth can be attributed to the high availability of funds, well-developed healthcare sector, growing prevalence of cancer, and rising clinical trials.
Europe bags the second spot in the global market and is predicted to exhibit healthy growth in the coming years, mainly due to the initiatives undertaken by the governments to support the growth of the pharmaceutical sector. The high availability of funds and the increased adoption of next-generation healthcare technology are further anticipated to favor the growth of the small molecule API market.
The Asia Pacific is predicted to demonstrate the highest CAGR as countries in this region have an abundance of raw materials, which are required for the manufacturing of drugs. Moreover, regulatory relaxations and low labor cost have further encouraged the players to invest in the market. APAC, being one of the significant exporters of small molecule drug, is likely to influence the market growth.
Get More Information on Global Small Molecule API Market Research Report- Forecast to 2027 @ https://www.marketresearchfuture.com/reports/small-molecule-api-market-763
Scope of Report
The report for Global Small Molecule API Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
List of Tables
Table 1 Global Small Molecule Api Market, by Type, 2014-2027 (Usd Million)
Table 2 Global Synthetic/chemical Api Market, by Region, 2014-2027 (Usd Million)
Table 3 Global Biological Api Market, by Region, 2014-2027 (Usd Million)
Table 4 Global Small Molecule Api Market, by Application, 2014-2027 (Usd Million)
Table 5 Global Small Molecule Api Market: Cardiovascular, by Region, 2014-2027 (Usd Million)
Table 6 Global Small Molecule Api Market: Oncology, by Region, 2014-2027 (Usd Million)
Table 7 Global Small Molecule Api Market: Diabetes, by Region, 2014-2027 (Usd Million)
Table 8 Global Small Molecule Api Market: Immunological Disorders, by Region, 2014-2027 (Usd Million)
Table 9 Global Small Molecule Api Market, by Manufacturing Methods, 2014-2027 (Usd Million)
Table 10 Global Small Molecule Api Market, by in-house Manufacturing, 2014-2027 (Usd Million)
List of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Small Molecule Api Market, by Type
Figure 4 Global Small Molecule Api Market, by Manufacturing Methods
Figure 5 Contract Manufacturing Organizations: Market Share Analysis (%)
Figure 6 North America Small Molecule Api Market, by Country (%)
Figure 7 North America Small Molecule Api Market, by Type
Figure 8 North America Small Molecule Api Market, by Application
Figure 9 North America Small Molecule Api Market, by Manufacturing Method
Figure 10 Europe Small Molecule Api Market, by Country (%)
Ask for your specific company profile and country level customization on reports.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Edibles.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.